AC Immune S.A.ACIUNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-6.9%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-6.9%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 25.16% |
| Q2 2025 | -11.35% |
| Q1 2025 | -20.46% |
| Q4 2024 | -387.06% |
| Q3 2024 | 124.18% |
| Q2 2024 | -27.42% |
| Q1 2024 | -276.52% |
| Q4 2023 | 68.67% |
| Q3 2023 | 10.04% |
| Q2 2023 | 3.88% |
| Q1 2023 | 6.59% |
| Q4 2022 | -38.72% |
| Q3 2022 | 31.19% |
| Q2 2022 | -4.22% |
| Q1 2022 | 11.41% |
| Q4 2021 | -33.66% |
| Q3 2021 | 16.52% |
| Q2 2021 | -13.95% |
| Q1 2021 | 14.18% |
| Q4 2020 | -2.66% |
| Q3 2020 | -20.69% |
| Q2 2020 | -104.68% |
| Q1 2020 | 60.46% |
| Q4 2019 | -206.77% |
| Q3 2019 | 207.78% |
| Q2 2019 | -126.58% |
| Q1 2019 | 533.15% |
| Q4 2018 | -8.59% |
| Q3 2018 | -21.30% |
| Q2 2018 | 4.06% |
| Q1 2018 | -378.91% |
| Q4 2017 | 147.36% |
| Q3 2017 | 28.67% |
| Q2 2017 | -30.38% |
| Q1 2017 | -98.34% |
| Q4 2016 | 47.63% |
| Q3 2016 | -170.32% |
| Q2 2016 | 309.62% |
| Q1 2016 | -10.58% |
| Q4 2015 | -127.78% |